Quadrant Capital Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-687
Closed -$29.1K 2786
2024
Q1
$29.1K Sell
687
-53
-7% -$2.24K ﹤0.01% 1679
2023
Q4
$30.9K Buy
740
+205
+38% +$8.57K ﹤0.01% 1622
2023
Q3
$20.2K Buy
535
+3
+0.6% +$113 ﹤0.01% 1708
2023
Q2
$20.2K Sell
532
-692
-57% -$26.2K ﹤0.01% 1712
2023
Q1
$29.8K Buy
1,224
+706
+136% +$17.2K ﹤0.01% 1496
2022
Q4
$15K Sell
518
-757
-59% -$22K ﹤0.01% 1781
2022
Q3
$38K Buy
1,275
+774
+154% +$23.1K 0.01% 1200
2022
Q2
$18K Buy
501
+394
+368% +$14.2K ﹤0.01% 1379
2022
Q1
$5K Sell
107
-522
-83% -$24.4K ﹤0.01% 1946
2021
Q4
$32K Buy
629
+493
+363% +$25.1K ﹤0.01% 1093
2021
Q3
$9K Buy
136
+38
+39% +$2.52K ﹤0.01% 1669
2021
Q2
$7K Hold
98
﹤0.01% 1751
2021
Q1
$7K Hold
98
﹤0.01% 1682
2020
Q4
$7K Buy
98
+38
+63% +$2.71K ﹤0.01% 1599
2020
Q3
$3K Buy
+60
New +$3K ﹤0.01% 1768
2018
Q4
Sell
-56
Closed -$4K 2319
2018
Q3
$4K Hold
56
﹤0.01% 1660
2018
Q2
$5K Hold
56
﹤0.01% 1586
2018
Q1
$4K Sell
56
-137
-71% -$9.79K ﹤0.01% 1637
2017
Q4
$17K Hold
193
0.01% 981
2017
Q3
$19K Sell
193
-265
-58% -$26.1K 0.01% 927
2017
Q2
$46K Buy
458
+105
+30% +$10.5K 0.02% 583
2017
Q1
$37K Buy
353
+171
+94% +$17.9K 0.02% 659
2016
Q4
$16K Buy
182
+157
+628% +$13.8K 0.01% 848
2016
Q3
$2K Sell
25
-7
-22% -$560 ﹤0.01% 1535
2016
Q2
$2K Buy
32
+18
+129% +$1.13K ﹤0.01% 1497
2016
Q1
$1K Buy
14
+3
+27% +$214 ﹤0.01% 1643
2015
Q4
$1K Sell
11
-50
-82% -$4.55K ﹤0.01% 1489
2015
Q3
$8K Hold
61
0.01% 726
2015
Q2
$8K Buy
+61
New +$8K 0.01% 757